Mayeta Clark 2015

Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against clinical malaria

March 17, 2015

Antibodies play major roles in immunity to malaria; however, a limited understanding of mechanisms mediating protection is a major barrier…

Read More

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a pooled analysis of individual patient data

March 15, 2015

The paper highlights underdosing of lumefantrine in young children and has also been incorporated into the latest WHO Antimalarial Therapeutic Guidelines.

Read More

Ultra-Sensitive Detection of Plasmodium falciparumby Amplification of Multi-Copy Subtelomeric Targets

March 3, 2015

This manuscript describes the development of a novel PCR method for detecting ultra low-density P. falciparum infections previously not detectable by any other method but contributing to ongoing transmission.

Read More

Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial

January 16, 2015

A large trial in nearly 2800 women showed a combination of sulphadoxine and pyrimethamine with azithromycin to decrease low birth weight and preterm birth in Papua New Guinea.

Read More

Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria

January 8, 2015

Plasmodium vivax can cause severe malaria, however its pathogenesis is poorly understood. In contrast to P. falciparum, circulating vivax parasitemia is low,…

Read More

Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission

November 18, 2014

This manuscript outlines the first mathematical model that explicitly models the contribution of relapsing infections to P. vivax transmission. This model has since served as the basis of more advanced models investigating both the effect of different intervention on P. vivax transmission and evolutionary advantages of different relapse phenotypes.

Read More

Immunological markers of vivax exposure and immunity: A Systematic Review and Meta-analysis

September 9, 2014

This study standardised protective immune responses across multiple populations to identify biomarkers of protective vivax immunity across populations of varying malaria transmission.

Read More

Global extent of chloroquine-resistant Plasmodium vivax a systematic review and meta-analysis

September 8, 2014

A meta-analysis of >191 clinical trials highlighting the complexity of defining P. vivax antimalarial efficacy. The paper demonstrates that the extent of chloroquine resistant P. vivax is far greater than previously appreciated

Read More

Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs

September 1, 2014

Our invited review highlighted that current pharmacokinetic-pharmacodynamic models exclude important factors such as host immunity and complexities of drug action. We highlighted a lack of statistical rigour in parameter estimation.

Read More

Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria

July 1, 2014

This study demonstrated than human antibodies to merozoites promote opsonic phagocytosis by monocytes, which is was associated with protective immunity to malaria in Africa children. The acquisition and boosting of these antibodies was defined.

Read More

1 9 10 11 12 13